Opdivo® (nivolumab)
for Lung Cancer

Opdivo (nivolumab) is an immunotherapy used to treat various cancers, including melanoma, non-small cell lung cancer, mesothelioma, renal cell carcinoma, Hodgkin lymphoma, and others. It is given as an intravenous infusion every 2 to 4 weeks, either alone or with other treatments like Yervoy or chemotherapy. Opdivo works by boosting the immune system’s ability to attack cancer cells, slowing tumor growth and spread.

Heart
Other top medicines used to treat Lung Cancer